NovaBridge Biosciences
Ragi
late-line treatment of solid tumors
Resolved
98days ago
Phase 1 readout · ~ Mar 31, 2026 estimated
What's at stake
Phase 1 trial results for Ragi in late-line treatment of solid tumors are due ~ Mar 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 15h ago
“Topline data from Phase 1b study for late-line treatment of solid tumors in combo with PD-(L)1”